Jamison Private Wealth Management, Inc. Crispr Therapeutics Ag Transaction History
Jamison Private Wealth Management, Inc.
- $657 Billion
- Q3 2024
A detailed history of Jamison Private Wealth Management, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Jamison Private Wealth Management, Inc. holds 5,698 shares of CRSP stock, worth $220,227. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,698
Previous 5,744
0.8%
Holding current value
$220,227
Previous $310 Million
13.71%
% of portfolio
0.04%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding CRSP
# of Institutions
490Shares Held
58MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$306 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$290 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$116 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$115 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$115 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.02B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....